Analysis of the METABRIC dataset (Curtis et al., 2012) showed that increased FOXM1 expression correlates with poorer survival in PIK3CA mutant breast cancer patients (Figure S6E), and that breast cancer-specific survival rate is decreased in ER+ breast cancer patients with FOXM1 copy number gain (Figure S6F). This evidence concerns the gene FOXM1 and breast cancer.